BACKGROUND: Surgical resection is the primary treatment for colon cancer, but use of laparoscopic approaches varies widely despite demonstrated shortand long-term benefits.
M
inimally invasive laparoscopic surgery for colon cancer has been used more frequently for some patients after clinical trials demonstrated its safety and oncologic similarity to open surgery. Shortterm benefits of laparoscopic resection include reduced analgesia, 1 fewer complications, [1] [2] [3] [4] decreased postoperative intensive care/skilled nursing, 3, 4 and shorter length of stay [1] [2] [3] [4] [5] [6] without increased rates of readmission or emergency visits. 7 Several, 2,3,5,6,8 but not all, 4 studies have documented decreased 30-day mortality. Compared with open resection, laparoscopic colectomy is associated with similar 5, 6, [9] [10] [11] [12] [13] or better 8 long-term oncologic and survival outcomes and cost savings. 4, 14, 15 Despite these benefits, laparoscopic surgery has not been widely adopted for eligible patients with colon cancer, and even among those who receive laparoscopic colectomy, unexplained hospital-level variation in outcomes (hospital center effect) exists. 16 Previous studies have shown extensive variability in laparoscopic surgery use based on characteristics of patients (eg, age, sex, race/ ethnicity, socioeconomic status, payer/insurance type, disease stage, and comorbidity), hospitals (eg, size/volume, teaching hospital status, urban/rural, and geographic region), 3, 5, 8, [17] [18] [19] [20] [21] and surgeon caseload. 22 To our knowledge, no studies have examined small area variability (eg, at the county level) in the use of laparoscopic surgery in the United States. Moreover, no studies concurrently examined variation across patients, hospitals, and geography.
This study describes variability in use of laparoscopic (vs open) surgery for colon cancer among Medicare patients. Identifying the level (patient, hospital, and/or geographic unit) at which variation is occurring and the characteristics associated with underuse of laparoscopic surgery for colon cancer would help direct interventions aimed at decreasing disparities in availability and accessinterventions that might have potential for cost savings and improving healthcare quality.
PATIENTS AND METHODS

Data Sources
Data were from the most recent release of an existing linkage of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database with Medicare claims data (2008-2011), supplemented with county-level demographic data from the 2010 US Census and the 2008-2012 American Community Survey. SEER is a nationally representative collection of population-based cancer registries collecting demographic, diagnostic, initial treatment, and survival data for 28% of the US population. 23 This study included 17 SEER registries: Connecticut, Iowa, New Mexico, Utah, Hawaii, New Jersey, Kentucky, Louisiana, Detroit (Michigan), San Francisco-Oakland (California), Atlanta (Georgia), Seattle-Puget Sound (Washington), rural Georgia, greater Georgia, Los Angeles County (California), San Jose-Monterey (California), and greater California. The Centers for Medicare & Medicaid Services (CMS) collect claims information for covered healthcare services from the time of an individual's Medicare enrollment until death. Use of the linked database provides detailed claims-related information, such as physician-and hospital-level variables, as well as the ascertainment of comorbidities before diagnosis, which are unavailable through the SEER cancer registry. The institutional review boards approved this study as nonhuman subjects research exempt from oversight.
Patient Sample
Eligibility included patients aged ≥66 years who underwent nonurgent/nonemergent surgical resection within 90 days of diagnosis for a first primary in situ or invasive colon cancer diagnosed during 2009-2011, who had both Medicare Parts A and B coverage during this period. Patients with unknown surgery type were excluded. Including patients aged ≥66 years allowed for a complete year of claims data (from 2008 records) before diagnosis to determine comorbidities. Diagnosis during 2009-2011 was selected because the International Classification of Diseases, Ninth Revision (ICD-9), procedure codes for laparoscopic colon resection became available on October 1, 2008. We excluded patients who were members of a health maintenance organization (HMO) or had incomplete Medicare Parts A and B coverage because of a lack of claims data. Similarly, patients identified by autopsy or death certificate were excluded from analysis. We identified patients with urgent/emergent colon cancer based ICD-9 codes for bowel obstruction (56089, 5609), perforation (56983), hemorrhage (5693, 5789), peritonitis (5670, 5672, 5678, 5679), or emergency inpatient admission (see Text, Supplemental Digital Content 1, http://links.lww.com/ DCR/A364, which details the exclusion criteria for urgent, emergent, and emergency procedures). Statistical Analysis χ2 tests were used to compare descriptive characteristics by surgery type. Mean annual surgeon caseload was treated as a hospital-level characteristic because of model complexity and based on the skewed distribution of the number of patients nested within surgeons. To account for lack of independence of patients within hospitals and within patient residential counties, we used a Bayesian cross-classified multilevel logistic model, which allows nesting within multiple separate, unrelated groups. 31 Covariates were forced into the models to calculate adjusted ORs and 95% CIs. Deviance Information Criterion was used to assess model fit, with lower values indicating better fit. WinBUGS (version 1.4.3, Medical Research Council, London, United Kingdom) was used to perform 5000 burn-in iterations of the cross-classified Bayesian analysis, with an additional 5000 iterations retained for parameter estimates.
Type of Surgery
To facilitate interpretation of the variance across hospitals and counties on a scale directly comparable with ORs for other covariates in the model, we calculated the median odds ratio (MOR). 32 Based on the random-effects variance component (V) from the regression model, MOR exp = ( . ) 0 95 V can be interpreted as the median value of the ratio of predicted odds of the outcome for 2 patients randomly selected from different hospitals (or counties) with equivalent covariates. An MOR of 1 indicates no variation in outcome across hospitals (or counties). Because of the 1-tailed testing of heterogeneity measures, 95% credible intervals (similar to CIs using the Frequentist approach) are not reported, and 1-tailed p values are used to indicate statistical significance. 33 We also estimated variability in laparoscopic surgery use across hospitals and counties with ≥30 patients. Predicted probability of receiving laparoscopic surgery was computed for each patient using model coefficients. These individual predicted probabilities were then averaged for all of the patients treated at a particular hospital and residing in a particular county to create hospital-and county-level predicted values. These predicted values were compared with the observed values across hospitals and counties.
RESULTS
Data were analyzed for 10,618 patients residing in 579 counties who underwent nonurgent/nonemergent colon cancer resection at 950 hospitals. Most patients were women (57.9%), white (84.0%), not dual enrolled in Medicaid (82.8%), and <85 years old (81.2%; Table 1 ). American Joint Commission on Cancer Stage II tumors were the most common (33.2%). The majority of tumors were moderately differentiated (65.2%), in the proximal colon (55.4%), and nonmucinous adenocarcinoma (87.7%). Surgeons with annual caseloads <10 performed 43.4% of all the surgeries in this analysis. Most patients (63.9%) resided in counties with 10% to 19% poverty.
Among the 93.7% of patients for whom surgeon specialty was available, 98.6% had a single surgeon. Patients primarily saw general surgeons (72.6%), colorectal surgeons (22.1%), or surgical oncologists (2.0%).
Laparoscopic Surgical Use
Overall, laparoscopic surgery was used for 47% of all resections, including 484 converted surgeries. All of the covariates differed significantly by surgery type. Laparoscopic surgery 
Adjusted Model
When adjusted, patients were 25% less likely to receive laparoscopic surgery if they were aged ≥85 years (vs 66-74 years) and 41% more likely if they did not receive Medicaid (vs Medicaid; Table 2 ). Men were 14% more likely than women to receive laparoscopic resection. Race and number of comorbidities did not predict laparoscopic resection. Patients with proximal (vs distal) tumors were 36% more likely to receive laparoscopic surgery, and patients with more advanced disease (stages II and III-IV each vs stage 0-I) and more aggressive tumors (grade 3 and 4 vs grade 1) were significantly less likely to undergo laparoscopic surgery. As hospital size increased, so did the odds of receiving laparoscopic surgery. Hospital teaching status was nonsignificant. Patients from counties with >20% of the population living in poverty (vs <10%) were 35% less likely to receive laparoscopic surgery.
Multilevel Variation
Because of missing data, 226 patients were excluded from cross-classified modeling (n = 10,392). In unadjusted models, significant variation in laparoscopic surgery use existed at hospital (MOR = 3.31; V = 1.58; p < 0.001) and county (MOR = 1.32; V = 0.09; p < 0.05) levels (Table 3) . When adjusted, hospital variation (adjusted MOR = 3.31; V = 1.58; p < 0.001) remained larger than county-level variation (adjusted MOR = 1.28; V = 0.07; p < 0.05).
Among the 85 hospitals with ≥30 patients with incident colon cancer, the observed percentage who received laparoscopic surgery ranged from 4.4% to 94.0% (Table 4) , whereas the predicted rate ranged from 8.1% to 91.3%. Six hospitals had observed percentage of laparoscopic surgery use below the lower bound of the 1-tailed 95% credible interval of the predicted percentage (laparoscopic surgery use was lower than expected), whereas 8% were above the upper bound (use was higher than expected).
Among the 76 counties with ≥30 patients with new colon cancer, the observed percentage who received laparoscopic surgery ranged from 0.0% to 82.5%, whereas the predicted rate ranged from 10.4% to 76.7%. Four counties had observed percentage of laparoscopic surgery use below the lower bound of the 95% credible interval of the predicted percentage (use was lower than expected), whereas 11% were above the upper bound (use was higher than expected).
DISCUSSION
We examined the role of patient, hospital, and geographic variability in nonurgent/nonemergent laparoscopic resection for colon cancer. Use varied across hospitals but less so across counties. When comparing observed and predicted values among hospitals and counties with ≥30 patients, patients in 8.9% of hospitals and 13.1% of counties received laparoscopic surgery below expected rates. At the patient level, sex, dual Medicare/Medicaid enrollment, older age, and tumor characteristics (stage, grade, and proximal location) were significant predictors of laparoscopic surgery. Annual surgeon caseload, hospital size, and high county poverty were also significant.
Study limitations include those typical of observational studies, including an inability to account for factors not reflected in the database, such as patient preferences, and other factors that may impact the use of laparoscopic approaches. Although we used the most recent release of the SEER-Medicare data set, there is an inherent time lag in using large linked data. As use continues to increase, more recent data may show higher proportions of colon cancer resections being performed laparoscopically. In addition, this study lacks generalizability to patients without Medicare, including younger patients or those with HMO coverage. We also had to exclude the Alaska Native SEER registry because of low cell counts. SEER includes a nationally representative sample of cancer patients but not hospitals. Colon cancer disproportionately affects older people, 34 so this study applies to the majority of patients with colon cancer. HMO market penetration has been associated with an increased likelihood of laparoscopic surgery use, as well as lower overall costs, 14 so our exclusion of patients with HMO coverage may underestimate laparoscopic use. However, Medicare Parts A and B provide complete claims data and therefore eliminate potential confounding because of different reimbursement plans. We were unable to examine the influence of specific comorbidities (eg, obesity) that are difficult to identify using claims data and have been associated with increased odds of conversion to open surgery. 35, 36 Surgeon caseload was included as a hospital-level variable rather than being nested within the hospital because of small numbers of patients for many providers and model complexity.
Our study extends knowledge by examining countylevel geographic variation and by using a Bayesian crossclassified multilevel model to quantify the variation in laparoscopic surgery use separately across hospitals and counties. Previously, geographic variation was examined at the census region 21 and hospital referral region 26 in the United States. Our model accounted for little of the county variation in our study, indicating that additional county-level factors are at work. A hotspot analysis in Ontario, Canada, found geographic variability at the neighborhood level (defined as 3-character postal forwarding sortation areas) associated with the presence of minimally invasive surgery fellowship training facilities; 14% of the population resided in cold spots, which is similar to our finding of underuse at the county level. 37 The ability to find geographic variation is related to the number of units examined. Smaller geographic divisions, such as census tracts, would have provided greater variability and may have resulted in different findings, but we were unable to use census tracts because of many tracts having <5 patients. Other studies found greater variability in colon cancer complications and 30-day mortality at the censustract versus hospital level, 27, 28 but the current study found greater variation at the hospital versus county level, possibly because of the larger geographic unit (county) of measurement.
A previous study found that surgeon caseload was positively associated with laparoscopic surgery. 22 We also found that, as surgeon caseload decreased, so did the odds of receiving laparoscopic resection. Less than 5% of patients in our study had surgery performed by surgeons with annual caseloads of ≥30 (based on the study population), whereas 43% had surgeons with annual caseloads of <10. These patients were 60% less likely to undergo laparoscopic surgery compared with patients seeing surgeons with the highest caseload.
Our study supports previous research indicating that laparoscopic surgery is influenced by patient-and hospital-level factors. 3, 5, 8, [17] [18] [19] [20] [21] However, our study goes beyond previous studies to show that our proxy for individuallevel low socioeconomic status and county-level poverty (<10% vs ≥20%) was significantly associated with laparoscopic surgery. One possible explanation for these differences in use associated with poverty may be differential access to providers. 38 Even at high-volume hospitals, socioeconomic disparities in the use of minimally invasive colorectal surgery persist after controlling for factors such as comorbidities. 39 Larger hospital size was also significant in the adjusted model. Because we excluded urgent/emergent surgeries, we did not use critical access designation in the current study. Only 2.7% (n = 281) of included patients had surgeries performed at critical access hospitals. Rather, we used total number of beds as an indicator of differences in hospital size. With >23% of surgeries performed at hospitals with <200 beds, improving access to laparoscopic colon cancer resection could have significant cost savings and improvements in local healthcare quality. A previous study found near-universal access to laparoscopic equipment at hospitals filing claims with Medicare, 26 so hospital-level variation is not likely attributed to equipment access. Although larger hospitals were more likely to perform laparoscopic surgery to treat their patients' colon cancer, none of the variables included in our model accounted for the variation across hospitals, as indicated by the lack of change between the unadjusted and adjusted models. More research is needed to identify modifiable factors with potential to correct this underuse. Studies have suggested that decision aids may help reduce regional variation in surgery type, 26 and practice guidelines have advocated for surgeon training, particularly at small, rural hospitals. 32 In addition, reimbursement through CMS value-based care models could incentivize that use of laparoscopic surgery for colon cancer, which may reduce variability across hospitals. A possible solution to unwarranted variation (variation unexplained by disease, patient preference, or evidence-based care) in access to health care is to increase shared patient-physician decision-making. 40 Patient education about initial screening referrals, selecting a treating physician, hospital quality, surgical options, and deciding where (which hospital) to have nonurgent/ nonemergent colon cancer surgery are likely more important than the county of residence, although county variation was also significant. For example, patients should be educated about the potential health and cost benefits of laparoscopic resection and given referrals to surgeons who perform it on a regular basis or to hospitals with higher laparoscopic resection rates so patients can make informed treatment decisions based on their preferences and cost considerations. However, certain patients, particularly poor and/or rural patients enrolled in Medicare/ Medicaid, may have fewer options about where to have surgery because of their financial and/or transportation constraints or because of hospital policies for treating patients based on their health insurance status.
CONCLUSION
Significant variability exists across hospitals, counties, and patients regarding the use of laparoscopic surgery for nonurgent/nonemergent colon cancer surgery; however, there is only limited county-level variability. Determining the sources of hospital-level variation and decreasing disparities in use at the patient level, particularly patients on Medicaid, are areas in which increased laparoscopic surgery use could maximize patient outcomes and reduce healthcare costs.
